Novartis Will Pay $390M To Settle False Claims Suit About Marketing Of 4 Drugs
NEW YORK — One week before trial, Novartis Pharmaceuticals Co. on Oct. 27 announced it has reached an agreement in principle to settle a False Claims Act lawsuit with the United...To view the full article, register now.
Already a subscriber? Click here to view full article